The aim of a randomized controlled trial was to see if aerobic and strength training can successfully slow cognitive decline. The results might surprise you.
This Week on NeurologyLive® — July 22, 2024
Special Episode: FDA Approves Donanemab for Early Symptomatic Alzheimer Disease
NeurologyLive® Friday 5 — July 19, 2024
Episode 116: Understanding Vorasidenib's Therapeutic Benefit on Neurocognition, Seizure Control in Diffuse Gliomas
FDA Grants Fast Track Designation for Longeveron’s Lomecel-B in Mild Alzheimer Disease
Eplontersen Effective in Hereditary Transthyretin-Mediated Amyloidosis Regardless of BMI Changes or Sex